Myocardial fibrosis (MF) is defined as excessive production and deposition of extra-cellular
matrix proteins that result in pathologic myocardial remodeling. Three types of MF have …

Cardiac magnetic resonance offers multiple facets in the diagnosis, risk stratification, and
management of patients with myocardial diseases. Particularly, its feature to precisely …

Background Giant cell myocarditis (GCM) and cardiac sarcoidosis (CS) are rare
inflammatory diseases of the myocardium with poor prognosis. Little is known about the …

BACKGROUND: Randomized trials in obstructive coronary artery disease (CAD) have
largely shown no prognostic benefit from coronary revascularization. Although there are …

Cardiac sarcoidosis (CS) is a form of inflammatory cardiomyopathy associated with
significant clinical complications such as high-degree atrioventricular block, ventricular …

Cardiac sarcoidosis is an infiltrative cardiomyopathy that results from granulomatous
inflammation of the myocardium and may present with high-grade conduction disease …

Sarcoidosis is a systemic granulomatous disease of unknown etiology with heterogeneous
clinical manifestations. It mainly affects adults in the third and fourth decade of life with a …

Aims To assess the current role of cardiac imaging in the diagnosis, management, and
follow-up of patients with acute myocarditis (AM) through a European Association of …

Sarcoidosis is a multisystem disorder of unknown etiology. The leading hypothesis involves
an antigen-triggered dysregulated T-cell-driven immunologic response leading to non …

Cardiac involvement is a major cause of morbidity and mortality in patients with sarcoidosis.
1, 2 Compared with many other manifestations of the disease, patients with cardiac …